je.st
news
GSK, Pfizer must lower price of vital vaccine: Medecins sans Frontieres
2015-01-25 03:07:53| Biotech - Topix.net
Two giant pharmaceutical companies should lower the price of a new vaccine against pneumococcal disease that is needed by children in developing countries, but is unaffordable for some of their governments, say the volunteer doctors of Medecins sans Frontieres . In a report on vaccine pricing, MSF says British company GlaxoSmithKline and US giant Pfizer should slash the price of the vaccines to US$5 per child in developing countries.
Tags: price
lower
sans
vital
Category:Biotechnology and Pharmaceuticals